Company Filing History:
Years Active: 2001
Title: **John Migton: Innovator in Effervescent Histamine H2 Antagonist Composition**
Introduction
John Migton is a notable inventor based in Clark, NJ, who has made significant contributions to the pharmaceutical field. His innovative approach in creating a stable effervescent composition has paved the way for advancements in histamine H2 antagonists.
Latest Patents
Migton holds one patent that stands out for its unique formulation. His patent focuses on an "Effervescent Histamine H2 Antagonist Composition," which incorporates a histamine H2 antagonist that remains stable even in the presence of acidic materials. Notably, the composition utilizes a non-hydroxy group containing acidulant, ensuring stability while being devoid of hydroxy group containing acidulants. Preferred acidulants in the formulation include adipic acid, succinic acid, and fumaric acid, with adipic acid being the favored option.
Career Highlights
John Migton has established a solid career at Bristol-Myers Squibb Company, a leading player in the biopharmaceutical sector. His dedication to research and development has enhanced the company’s ability to deliver innovative therapeutic solutions to patients in need.
Collaborations
Throughout his tenure, Migton has collaborated closely with his coworker, Mamoun M Hussein. Their partnership highlights the importance of teamwork in driving innovations forward in complex scientific and medical fields.
Conclusion
John Migton’s work exemplifies the spirit of innovation within the pharmaceutical industry. His patented effervescent histamine H2 antagonist composition not only showcases his inventive capabilities but also contributes significantly to the development of more effective therapeutic alternatives. With a proactive approach and strong collaborations, Migton continues to be an influential figure in advancing healthcare solutions.